ANG Lifesciences India
ANG Lifesciences India Share Price Chart
ANG Lifesciences India last traded at ₹34.53 (2026-10-13). Over the past month the stock moved -3.5%, three months the stock moved +27.9%, year the stock moved +1.2%. Its closing range over 52 weeks is ₹19.31 – ₹41.07, with the latest close 15.9% below the high.
Closing prices up to 2026-10-13.
About ANG Lifesciences India
Incorporated in 2006, ANG Lifesciences India Ltd is in the business of pharmaceuticals products & formulations, and packaging and printing.[1]
Business Overview:[1][2][3] ANGLIL is a part of the ANG Group which is a WHO-GMP–certified consortium of pharmaceutical companies. The company is engaged in the manufacturing of pharmaceuticals & allied products which include finished formulations in Non-Beta Lactam, Beta Lactam, Cephalosporin, and Carbapenem segments.
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), ANG Lifesciences India reported sales of ₹15.30 crore (-37.8%) and net profit of ₹-4.24 crore, compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 15.30 | -1.95 | -12.75 | -4.24 | -3.25 |
| Mar 2026 | 23.50 | 2.68 | 11.40 | -1.38 | -1.06 |
| Dec 2025 | 18.73 | -2.68 | -14.31 | -4.75 | -3.64 |
| Sep 2025 | 26.05 | 0.08 | 0.31 | -2.95 | -2.26 |
| Jun 2025 | 24.60 | 0.65 | 2.64 | -2.01 | -1.54 |
| Mar 2025 | 16.82 | -0.70 | -4.16 | -2.06 | -1.58 |
| Dec 2024 | 24.73 | -2.15 | -8.69 | -5.19 | -3.97 |
| Sep 2024 | 32.88 | 2.28 | 6.93 | -2.09 | -1.60 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -1.1% | +33.3% | -55.5% | +33.6% | -20.8% | -24.3% | +39.7% | -37.8% |
| Operating profit growth | +37.3% | – | -120.8% | – | -96.5% | – | – | -400.0% |
| Net profit growth | – | – | – | – | – | – | – | – |
| EPS growth | – | – | – | – | – | – | – | – |
| OPM % | 6.9% | -8.7% | -4.2% | 2.6% | 0.3% | -14.3% | 11.4% | -12.8% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), ANG Lifesciences India reported sales of ₹93.00 crore (+0.0%) and net profit of ₹-11.00 crore, compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 93.00 | 1.00 | 1.00 | -11.00 | -8.49 |
| Mar 2025 | 93.00 | -2.00 | -2.00 | -12.00 | -9.50 |
| Mar 2024 | 145.00 | 10.00 | 7.00 | -10.00 | -7.77 |
| Mar 2023 | 220.00 | 15.00 | 7.00 | 0.00 | -0.20 |
| Mar 2022 | 354.00 | 68.00 | 19.00 | 40.00 | 31.02 |
| Mar 2021 | 154.00 | 14.00 | 9.00 | 7.00 | 5.26 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales growth | +129.9% | -37.9% | -34.1% | -35.9% | +0.0% |
| Operating profit growth | +385.7% | -77.9% | -33.3% | -120.0% | – |
| Net profit growth | +471.4% | -100.0% | – | – | – |
| EPS growth | +489.7% | -100.6% | – | – | – |
| OPM % | 19.0% | 7.0% | 7.0% | -2.0% | 1.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for ANG Lifesciences India.
Get Free AI Stock Analysis FREE →Latest News
-
ANG Lifesciences fixes AGM date, approves director re-appointments - scanx.trade
Frequently Asked Questions
What is the share price of ANG Lifesciences India today?
ANG Lifesciences India shares were last quoted at ₹34.53 (-5.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of ANG Lifesciences India?
ANG Lifesciences India has a price-to-earnings (P/E) ratio of -7.29 and a price-to-book (P/B) ratio of 1.10. The industry P/E is 52.82.
What is the 52-week high and low of ANG Lifesciences India?
The 52-week high of ANG Lifesciences India is ₹49.69 and the 52-week low is ₹17.63.
What is the market cap of ANG Lifesciences India?
The market capitalisation of ANG Lifesciences India is about ₹53.63 crore.
How did ANG Lifesciences India perform in its latest quarterly results?
In the latest quarter (Jun 2026), ANG Lifesciences India reported sales of ₹15.30 crore (-37.8%) and net profit of ₹-4.24 crore, compared with the same quarter last year.
Is ANG Lifesciences India a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, ANG Lifesciences India has a 3-year ROE of -15.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in ANG Lifesciences India?
Promoters hold about 70.60% of ANG Lifesciences India.
Which sector does ANG Lifesciences India belong to?
ANG Lifesciences India belongs to the Biotechnology & Medical Research sector.
Other Biotechnology & Medical Research stocks
- Biocon
- Concord Biotech
- Sun Pharma Advanced Research Company
- Windlas Biotech
- Arvee Laboratories
- Softrak Venture Investment
- Vivo Biotech
- Genomic Valley Biotech
All Biotechnology & Medical Research stocks · Browse all stocks A–Z